|
Programme |
|
|
| FRIDAY,
OCTOBER 19, 2007 |
|
| 8.00-9.00 |
Registration |
|
| Session
1 : |
Stem cells
from cord blood - Chair: G. Kögler |
|
| 09.00-09.30 |
Cord
blood-derived very small embryonic like (VSEL) stem
cells |
M. Ratajczak
(USA) |
| 09.30-10.00 |
Early events
in hematopoietic stem cell development |
E. Dzierzak (Netherlands)
|
| 10.00-10.30 |
Functional
characterization of stem cell subpopulations in cord
blood |
G. Kögler (Germany)
|
| 10.30-11.00 |
Coffee
Break |
|
| 11.00-11.30 |
Mesenchymal
stem cells are derived from a subset of perivascular
cells present in all human tissues |
B. Péault
(USA) |
| 11.30-12.00 |
Hemopoietic
stem cell generation in the mouse embryo |
A. Cumano (France) |
| 12.00-12.30 |
Notch
signaling in hematopoietic stem cell differentiation:
implications for cord blood transplantation |
I. Bernstein (USA) |
| 12.30-13.30 |
Buffet
Lunch and poster viewing |
|
| Session 2
: |
Mesenchymal cells - Chair: E. J. Shpall |
|
| 13.30-14.00 |
The
mesenchymal paradigm |
W.E. Fibbe (Netherlands) |
| 14.00-14.30 |
Early fetal
MSC and maternal and fetal tissue repair |
N.M. Fisk (UK) |
| Session 3
: |
Non
hemopoietic stem cells - Chair: D. Scadden |
|
| 14.30-15.00 |
Tissue
regeneration potential in human umbilical cord blood |
A. Nagler
(Israel) |
| 15.00-15.30 |
Circulating
endothelial progenitor cells: potential cell therapy
product and value as biological marker in diseases
involving angiogenesis |
G. Uzan (France) |
| 15.30-16.00 |
Therapeutic
potential of epidermal stem cells derived from both
embryonic and somatic tissues |
D. Aberdam (France) |
| 16.00-16.30 |
Non
hematopoietic human umbilical cord blood stem cell line
differentiating into neural lineages |
L. Buzanska (Poland) |
|
16.30-17.00 |
Coffee
Break |
|
| 17.00-17.30 |
The umbilical
cord as a stem cell source : cells derived from
Wharton's Jelly |
M.L. Weiss
(USA) |
| 17.30-18.00 |
Re-defining
human circulating endothelial progenitor cells |
M.C. Yoder
(USA) |
| 18.00-18.30 |
Conditional
interference with T-cell and dendritic cell responses of
cord blood derived Unrestricted Somatic Stem Cells (USSC) |
P. Wernet (Germany) |
| |
|
|
|
SATURDAY, OCTOBER 20, 2007 |
|
| Session 4
: |
Immunological properties - Chair: E. Gluckman |
|
| 08.30-08.50 |
Umbilical
cord blood-derived T cells expressing chimeric antigen
receptor to target B-cell malignancies |
L. Cooper
(USA) |
|
08.50-09.10 |
Immune
reconstitution of cord blood recipients |
K. Komanduri
(USA) |
|
09.10-09.30 |
Graft versus
host disease of cord blood transplant patients |
D. Couriel
(USA) |
| Session 5
: |
Clinical
results - Chair: J. Wagner |
|
|
09.30-09.50 |
Role of HLA
and cell dose in cord blood transplant |
E. Gluckman (France) |
|
09.50-10.10 |
Nonmyeloablative stem cell transplantation |
R. Champlin
(USA) |
|
10.10-10.30 |
Double versus
expanded cord blood transplant: a prospective,
randomized trial |
M. de Lima
(USA) |
|
10.30-11.00 |
Coffee
Break |
|
|
11.00-11.20 |
Unrelated
cord blood transplants in hereditary disorders |
J. Kurtzberg
(USA) |
|
11.20-11.40 |
Cord blood
transplantation in adults |
J. Wagner
(USA) |
|
11.40-12.00 |
CIBMTR
comparisons of cord blood and bone marrow
transplantation |
M. Horowitz
(USA) |
|
12.00-12.20 |
Comparison of
cord blood transplant to other sources of cells |
V. Rocha (France) |
|
12.20-12.45 |
Discussion |
|
|
12.45-14.00 |
Lunch |
|
|
14.00-14.20 |
Cord blood
transplants in children |
F. Locatelli
(Italy) |
|
14.20-14.40 |
Cord blood
transplant in adults with AML |
W. Arcese (Italy) |
|
14.40-15.00 |
Prognostic
factors after UCB transplants in adults with hematologic
malignancies:
Are the currently accepted guidelines for selecting the
best UCB unit adequate? |
G. Sanz (Spain) |
|
15.00-15.20 |
Structure of
data collection |
M. Horowitz
(USA) & F. Garnier (France) |
| 15.20-15:35 |
Results of a
meta analysis of CIBMTR, NCBP and Eurocord |
Y. Cohen
(Israel) |
| 15.20-15.50 |
Discussion |
|
| Session 6
: |
Ex vivo
expansion - Chair: H.E. Broxmeyer |
|
|
15.50-16.10 |
The
multifaceted sides of cord blood expansion |
W. Piacibello
(Italy) |
|
16.10-16.30 |
Copper
chelator and other technologies for cord expansion |
E.J. Shpall
(USA) |
|
16.30-16.50 |
Ex vivo
expansion of cord blood cell |
I. McNiece
(USA) |
|
16.50-17.10 |
Coffee
Break |
|
|
17.10-18.10 |
Selected
abstracts and poster presentation |
|
|
|
Characterization of mesenchymal stromal cells derived
from umbilical cord |
C. Navarrete
et al (UK) |
|
|
|
|
|
SUNDAY, OCTOBER 21, 2007 |
|
| Session 7
: |
Graft
facilitation / Homing - Chair: W.E. Fibbe |
|
| 08.30-09.00 |
Mechanistic
insights into engraftment |
H.E.
Broxmeyer (USA) |
| 09.00-09.30 |
Regulation of
stem cell homing, retention and mobilization |
T. Lapidot
(Israel) |
| 09.30-10.00 |
Stem cells
and their niche: a leverage point for therapy |
D. Scadden
(USA) |
|
10.00-10.30 |
Regulation of
self-renewing divisions of HSC by human mesenchymal
stroma cells - Clinical consequences |
A. Ho
(Germany) |
| 10.30-11.00 |
Direct
intra-bone (IBM) transplant of cord blood cells |
F. Frassoni
(Italy) |
|
11.00-11.30 |
Coffee
Break |
|
| Session 8
: |
Cord blood
transplant: banking, organization, regulatory issues -
Chair: TBA |
|
|
11.30-11.45 |
Netcord
organization |
J. Garcia
(Spain) |
| 11.45-12.00 |
Establishing
a National Cord Blood Program, the United States
Experience |
M. Boo (USA) |
|
12.00-12.15 |
Biological
resource center |
P. Rebulla
(Italy) |
| 12.15-12.30 |
Development of cord
blood banking and transplantation in Asia;
Report from Asia Cord |
T. Takahashi
(Japan) |
| 12.30-12.40 |
London cord blood bank |
C. Navarrete
(UK) |
| 12.40-12.50 |
Sibling cord
blood banking and transplantation |
B. Lubin
(USA) |
| 12.50-13.00 |
Autologous
cord blood banking: a need or an illusion? |
Y. Beguin
(Belgium) |
| 13.00-13.10 |
Economic
models of cord blood banks |
G. Katz
Benichou (France) |
| 13.10-13.30 |
Discussion |
|
| 13.30 |
End of
the meeting |